96 related articles for article (PubMed ID: 21963224)
1. An RNA aptamer that specifically binds pancreatic adenocarcinoma up-regulated factor inhibits migration and growth of pancreatic cancer cells.
Kim YH; Sung HJ; Kim S; Kim EO; Lee JW; Moon JY; Choi K; Jung JE; Lee Y; Koh SS; Rhee SG; Heo K; Kim IH
Cancer Lett; 2011 Dec; 313(1):76-83. PubMed ID: 21963224
[TBL] [Abstract][Full Text] [Related]
2. PAUF functions in the metastasis of human pancreatic cancer cells and upregulates CXCR4 expression.
Lee Y; Kim SJ; Park HD; Park EH; Huang SM; Jeon SB; Kim JM; Lim DS; Koh SS
Oncogene; 2010 Jan; 29(1):56-67. PubMed ID: 19784070
[TBL] [Abstract][Full Text] [Related]
3. MIF inhibitor, ISO-1, attenuates human pancreatic cancer cell proliferation, migration and invasion in vitro, and suppresses xenograft tumour growth in vivo.
Cheng B; Wang Q; Song Y; Liu Y; Liu Y; Yang S; Li D; Zhang Y; Zhu C
Sci Rep; 2020 Apr; 10(1):6741. PubMed ID: 32317702
[TBL] [Abstract][Full Text] [Related]
4. Efficient targeting and tumor retardation effect of pancreatic adenocarcinoma up-regulated factor (PAUF)-specific RNA replacement in pancreatic cancer mouse model.
Kim YH; Moon JY; Kim EO; Lee SJ; Kang SH; Kim SK; Heo K; Lee Y; Kim H; Kim KT; Kim D; Song MS; Lee SW; Lee Y; Koh SS; Kim IH
Cancer Lett; 2014 Mar; 344(2):223-31. PubMed ID: 24189457
[TBL] [Abstract][Full Text] [Related]
5. Ellagic acid inhibits the proliferation of human pancreatic carcinoma PANC-1 cells in vitro and in vivo.
Cheng H; Lu C; Tang R; Pan Y; Bao S; Qiu Y; Xie M
Oncotarget; 2017 Feb; 8(7):12301-12310. PubMed ID: 28135203
[TBL] [Abstract][Full Text] [Related]
6. SIRT1 inhibits proliferation of pancreatic cancer cells expressing pancreatic adenocarcinoma up-regulated factor (PAUF), a novel oncogene, by suppression of β-catenin.
Cho IR; Koh SS; Malilas W; Srisuttee R; Moon J; Choi YW; Horio Y; Oh S; Chung YH
Biochem Biophys Res Commun; 2012 Jun; 423(2):270-5. PubMed ID: 22640743
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic adenocarcinoma upregulated factor (PAUF) confers resistance to pancreatic cancer cells against oncolytic parvovirus H-1 infection through IFNA receptor-mediated signaling.
Kaowinn S; Cho IR; Moon J; Jun SW; Kim CS; Kang HY; Kim M; Koh SS; Chung YH
Biochem Biophys Res Commun; 2015 Apr; 459(2):313-318. PubMed ID: 25727013
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic adenocarcinoma upregulated factor, a novel endothelial activator, promotes angiogenesis and vascular permeability.
Kim SJ; Lee Y; Kim NY; Hwang Y; Hwang B; Min JK; Koh SS
Oncogene; 2013 Aug; 32(31):3638-47. PubMed ID: 22907431
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic cancer induces muscle wasting by promoting the release of pancreatic adenocarcinoma upregulated factor.
Yoo W; Choi H; Son YH; Lee J; Jo S; Jung D; Kim YJ; Koh SS; Yang YR; Kwon ES; Lee KP; Noh KH; Kim KW; Ko Y; Jun E; Kim SC; Kim S
Exp Mol Med; 2021 Mar; 53(3):432-445. PubMed ID: 33731895
[TBL] [Abstract][Full Text] [Related]
10. DCPP1 is the mouse ortholog of human PAUF that possesses functional analogy in pancreatic cancer.
Song H; Song J; Kim YJ; Jeong HH; Min HJ; Koh SS
Biochem Biophys Res Commun; 2017 Dec; 493(4):1498-1503. PubMed ID: 28988106
[TBL] [Abstract][Full Text] [Related]
11. Rottlerin suppresses growth of human pancreatic tumors in nude mice, and pancreatic cancer cells isolated from Kras(G12D) mice.
Huang M; Tang SN; Upadhyay G; Marsh JL; Jackman CP; Srivastava RK; Shankar S
Cancer Lett; 2014 Oct; 353(1):32-40. PubMed ID: 25050737
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic adenocarcinoma up-regulated factor (PAUF) enhances the accumulation and functional activity of myeloid-derived suppressor cells (MDSCs) in pancreatic cancer.
Song J; Lee J; Kim J; Jo S; Kim YJ; Baek JE; Kwon ES; Lee KP; Yang S; Kwon KS; Kim DU; Kang TH; Park YY; Chang S; Cho HJ; Kim SC; Koh SS; Kim S
Oncotarget; 2016 Aug; 7(32):51840-51853. PubMed ID: 27322081
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic adenocarcinoma up-regulated factor (PAUF), a novel up-regulated secretory protein in pancreatic ductal adenocarcinoma.
Kim SA; Lee Y; Jung DE; Park KH; Park JY; Gang J; Jeon SB; Park EC; Kim YG; Lee B; Liu Q; Zeng W; Yeramilli S; Lee S; Koh SS; Song SY
Cancer Sci; 2009 May; 100(5):828-36. PubMed ID: 19302292
[TBL] [Abstract][Full Text] [Related]
14. Ellagic acid inhibits human pancreatic cancer growth in Balb c nude mice.
Zhao M; Tang SN; Marsh JL; Shankar S; Srivastava RK
Cancer Lett; 2013 Sep; 337(2):210-7. PubMed ID: 23684930
[TBL] [Abstract][Full Text] [Related]
15. The bisphosphonate incadronate inhibits intraperitoneal dissemination in an in vivo pancreatic cancer model.
Takiguchi S; Nishino Y; Inoue K; Ikeda M; Kataoka Y; Matsusue K; Nishiyama K; Iguchi H
Oncol Rep; 2012 Jul; 28(1):111-6. PubMed ID: 22484715
[TBL] [Abstract][Full Text] [Related]
16. Targeted Delivery of C/EBPα -saRNA by Pancreatic Ductal Adenocarcinoma-specific RNA Aptamers Inhibits Tumor Growth In Vivo.
Yoon S; Huang KW; Reebye V; Mintz P; Tien YW; Lai HS; Sætrom P; Reccia I; Swiderski P; Armstrong B; Jozwiak A; Spalding D; Jiao L; Habib N; Rossi JJ
Mol Ther; 2016 Jun; 24(6):1106-1116. PubMed ID: 26983359
[TBL] [Abstract][Full Text] [Related]
17. Periostin-binding DNA aptamer inhibits breast cancer growth and metastasis.
Lee YJ; Kim IS; Park SA; Kim Y; Lee JE; Noh DY; Kim KT; Ryu SH; Suh PG
Mol Ther; 2013 May; 21(5):1004-13. PubMed ID: 23511245
[TBL] [Abstract][Full Text] [Related]
18. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
[TBL] [Abstract][Full Text] [Related]
19. Identification of TAX2 peptide as a new unpredicted anti-cancer agent.
Jeanne A; Sick E; Devy J; Floquet N; Belloy N; Theret L; Boulagnon-Rombi C; Diebold MD; Dauchez M; Martiny L; Schneider C; Dedieu S
Oncotarget; 2015 Jul; 6(20):17981-8000. PubMed ID: 26046793
[TBL] [Abstract][Full Text] [Related]
20. Silencing of pancreatic adenocarcinoma upregulated factor by RNA interference inhibits the malignant phenotypes of human colorectal cancer cells.
Liu PF; Wu YY; Hu Y; Wang L; He SB; Zhu YB; Zhu XG
Oncol Rep; 2013 Jul; 30(1):213-20. PubMed ID: 23677445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]